Gilead responds to radcivir clinical trial: free to determine effective safety

category:Global
 Gilead responds to radcivir clinical trial: free to determine effective safety


Gilead said it will provide readcivir free of charge to carry out clinical trials (source: pear video)

Gileads drug in research, radcivir, has officially started clinical trials. At present, the drug is considered to have great potential in anti new coronavirus. Gilead said in the pear video that it would provide research drugs free of charge, provide suggestions for research design and implementation, and support two clinical trials for people infected with new coronavirus.

(function() {(window. Slotbydup = window. Slotbydup| []). Push ({ID: u5811557, container: ssp_, async: true});}) (); source of this article: Li video responsibility editor: Han Jiapeng nn9841